Rasagiline Mesylate
Rank #482 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.5M
Total Cost
47,985
Total Claims
$14.5M
Total Cost
1,518
Prescribers
$303
Cost per Claim
6,611
Beneficiaries
94,120
30-Day Fills
$9,576
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.5M total
Top Prescribers of Rasagiline Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | David Kreitzman | Neurology | Commack, NY | 707 | $247K |
| 2 | Mark Ledoux | Emergency Medicine | Memphis, TN | 432 | $135K |
| 3 | Guy Schwartz | Neurology | East Setauket, NY | 269 | $125K |
| 4 | Irene Oh | Neurology | Carlsbad, CA | 368 | $120K |
| 5 | Tziporah Kay | Physician Assistant | Brooklyn, NY | 230 | $104K |
| 6 | George Plotkin | Neurology | Tyler, TX | 274 | $96K |
| 7 | Catherine Claro | Nurse Practitioner | New York, NY | 223 | $87K |
| 8 | Daniel Kremens | Neurology | Philadelphia, PA | 242 | $85K |
| 9 | Sherrie Gould | Nurse Practitioner | La Jolla, CA | 200 | $84K |
| 10 | Mary Scott | Nurse Practitioner | Toledo, OH | 216 | $80K |
| 11 | Lawrence Elmer | Neurology | Toledo, OH | 220 | $80K |
| 12 | Julie Leegwater-Kim | Neurology | Burlington, MA | 229 | $79K |
| 13 | Alejandro Forteza | Neurology | Miami, FL | 152 | $75K |
| 14 | Dean Sutherland | Neurology | Sarasota, FL | 188 | $71K |
| 15 | Ricardo Gonzalez | Neurology | Sarasota, FL | 274 | $71K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 479 | Lanthanum Carbonate (Lanthanum Carbonate) | $14.7M | 13,783 |
| 480 | Mometasone Furoate (Mometasone Furoate) | $14.7M | 266,966 |
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology